Holen Sie sich die Stockscreener-App
13.49
3.30%
-0.46
Handel nachbörslich:
13.56
0.07
+0.52%
Finanzdaten der Cullinan Therapeutics Inc-Aktie (CGEM)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
0.60%
55.26
|
55.59 | 75.80 | 55.00 | 48.85 |
| Operating Income/Loss |
0.60%
-55.26
|
-55.59 | -75.80 | -55.00 | -48.85 |
| Income/Loss From Continuing Operations Before Tax |
0.20%
-50.71
|
-50.61 | -70.06 | -48.50 | -40.56 |
| Income/Loss From Continuing Operations After Tax |
0.20%
-50.71
|
-50.61 | -70.06 | -48.50 | -40.56 |
|
Net Income/Loss
|
0.20%
-50.71
|
-50.61 | -70.06 | -48.50 | -40.56 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):